Thursday, July 10, 2014





Sanofi-Aventis to pay $109M kickbacks settlement


February 19. 2013 10:50PM
Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


(AP) The U.S. subsidiaries of French pharmaceutical giant Sanofi will pay $109 million to settle allegations they gave kickbacks to induce doctors to buy and prescribe Hyalgan, a knee injection.


The Justice Department alleges that Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LLC violated the False Claims Act by giving doctors thousands of free units of Hyalgan as the drug faced pressure from a lower-priced competitor.


The agency also alleges Sanofi submitted false reports on the average sale price of Hyalgan that excluded the free units, causing Medicare and other federal health care programs to reimburse the company at inflated rates.


In a statement, Sanofi US said it cooperated fully with the government review and existing financial reserves will cover the settlement. The Bridgewater, N.J., company said it voluntarily stopped sampling Hyalgan in 2009.


Associated Press


Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds